BDBM423307 US10501452, Compound 13

SMILES CN1CCc2ccc(OCCCN3CCN(CC3)c3ccc4OCOc4c3)cc2C1=O

InChI Key InChIKey=YTMDEVVXDYXXMD-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 423307   

Target5-hydroxytryptamine receptor 2A(Rat)
Nhwa Pharma.

US Patent
LigandPNGBDBM423307(US10501452, Compound 13)
Affinity DataKi:  3.60nMAssay Description:5-HT2A:(1) The prepared membrane was applied with buffer, and homogenizer was used for evenly dispersing. 15 tubes were mixed into a 100 ml container...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
US Patent

Target5-hydroxytryptamine receptor 1A(Rat)
Nhwa Pharma.

US Patent
LigandPNGBDBM423307(US10501452, Compound 13)
Affinity DataKi:  12.8nMAssay Description:5-HT1A: (1) The prepared membrane was applied with appropriate amount of buffer, and homogenizer was used for evenly dispersing. 15 tubes were mixed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Nhwa Pharma.

US Patent
LigandPNGBDBM423307(US10501452, Compound 13)
Affinity DataKi:  235nMAssay Description:D2:Procedures(1) The prepared membrane was applied with appropriate amount of buffer, and homogenizer was used for evenly dispersing. 15 tubes were m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
US Patent